India to Turkey: Syringe Export Trade Route

The India to Turkey Syringe corridor is one of India's established pharmaceutical export routes, with 68 shipments documented worth a combined $10.8M USD. The route is dominated by INDIAN IMMUNOLOGICALS LIMITED, which alone accounts for roughly 99% of all export value, reflecting the consolidated nature of India's syringe manufacturing sector.

Across 11 active suppliers, the average shipment value stands at $158.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 73% of all shipments, consistent with syringe's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 21 days port-to-port. The route has recorded an annual growth rate of 17.3%, placing it at rank #4 among India's top syringe export destinations globally.

On the import side, key buyers of Indian syringe in Turkey include CENTURION ILAC SANAYI VE TICARET AN, CENTURION ILAC SANAYI VE TICARET, CENTURION ILAC SANAYI VE TICARET AN ONIM SIRKETI and 14 others. CENTURION ILAC SANAYI VE TICARET AN is the single largest importer with 34 shipments valued at $8.7M USD.

India's syringe exports to Turkey are driven primarily by a handful of large-scale manufacturers. INDIAN IMMUNOLOGICALS LIMITED with 39 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 11 active exporters signals a competitive but concentrated market — buyers in Turkey benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — INDIAN IMMUNOLOGICALS LIMITED, HELI PHARMA, HEIL PHARMA — together account for 100% of total trade value on this route. The average shipment value of $158.2K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as abhayrab 0.5ml b.p (human rabies vaccinewith disposable syringe and diluent) batch no:25urab003 & 25urab011 and abhayrab 0.5 ml b.p (human rabies vaccine with disposable syringe and diluent),batch no:25urab002 & 25urab003, suggesting that buyers in Turkey tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, CENTURION ILAC SANAYI VE TICARET AN is the largest importer with 34 shipments worth $8.7M USD — representing 81% of all syringe imports from India on this route. A total of 17 buyers are active on this corridor.